These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1622 related articles for article (PubMed ID: 23878165)
1. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165 [TBL] [Abstract][Full Text] [Related]
2. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094 [TBL] [Abstract][Full Text] [Related]
3. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556 [TBL] [Abstract][Full Text] [Related]
4. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health. Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236 [TBL] [Abstract][Full Text] [Related]
5. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Piche T Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256 [TBL] [Abstract][Full Text] [Related]
6. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894 [TBL] [Abstract][Full Text] [Related]
7. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Akbar A; Yiangou Y; Facer P; Brydon WG; Walters JR; Anand P; Ghosh S Gut; 2010 Jun; 59(6):767-74. PubMed ID: 20551462 [TBL] [Abstract][Full Text] [Related]
8. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome]. Li MR; Jiang K; Zhang QY Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966 [TBL] [Abstract][Full Text] [Related]
9. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases]. Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636 [TBL] [Abstract][Full Text] [Related]
10. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome. von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904 [TBL] [Abstract][Full Text] [Related]
11. Multispecies probiotic protects gut barrier function in experimental models. Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335 [TBL] [Abstract][Full Text] [Related]
13. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731 [TBL] [Abstract][Full Text] [Related]
14. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795 [TBL] [Abstract][Full Text] [Related]
15. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Nielsen OH; Rüdiger N; Gaustadnes M; Horn T Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176 [TBL] [Abstract][Full Text] [Related]
16. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099 [TBL] [Abstract][Full Text] [Related]
17. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197 [TBL] [Abstract][Full Text] [Related]
18. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression. Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303 [TBL] [Abstract][Full Text] [Related]
19. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]